Smoking cessation in pregnancy: Why, how, and what next...

Julie T. Crawford, Jorge E. Tolosa, Robert L. Goldenberg

Research output: Contribution to journalReview article

32 Scopus citations

Abstract

Smoking cessation in pregnancy has been shown to reduce low birth weight, preterm birth, and infant morbidities. The effectiveness and safety profile of current cessation approaches in pregnancy are presented. The highest cessation rates are associated with counseling and behavioral interventions. Further studies are needed to evaluate the safety and efficacy of pharmacotherapy in pregnancy including nicotine replacement therapy, bupropion and the recently approved drug Varenicline. The risks and benefits of nicotine replacement therapy in heavy smokers and bupropion are discussed. Data on fetal risk are not yet available for Varenicline.

Original languageEnglish (US)
Pages (from-to)419-435
Number of pages17
JournalClinical Obstetrics and Gynecology
Volume51
Issue number2
DOIs
StatePublished - Jun 1 2008

Keywords

  • Bupropion
  • Cessation
  • Nicotine replacement therapy
  • Pregnancy
  • Smoking
  • Tobacco use
  • Varenicline

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Smoking cessation in pregnancy: Why, how, and what next...'. Together they form a unique fingerprint.

  • Cite this